CURE Pharmaceutical Holding Corp. said it secured $1 million in bridge financing from certain investors for working capital and a potential uplisting to Nasdaq.

The Oxnard, Calif.-based specialty pharmaceutical and bioscience company said that through the investment it plans to develop its product pipeline.

The company trades on the OTC under the symbol CURR.

Alexander Capital LP acted as the sole placement agent for the transaction.